Rachal Laprairie v. HHS - Influenza, Guillain-Barré Syndrome (“GBS”) (2017)
Case summary [AI summaries can sometimes make mistakes]
On April 18, 2017, Rachal Lapairie filed a petition alleging Guillain-Barré Syndrome (GBS) as a result of receiving an influenza and tetanus-acellular pertussis (Tdap) vaccine on October 8, 2013. The respondent denied that the vaccines caused the petitioner's GBS or any other injury.
The parties reached a stipulation to resolve the case, and the Special Master adopted the terms of this stipulation. The court awarded Rachal Lapairie $195,000.00 as a lump sum, representing compensation for all damages available under the program.
The decision was issued by Special Master Laura D. Millman on April 18, 2017.
The public decision does not describe the petitioner's specific symptoms, medical history, diagnostic tests, treatments, or the specific mechanism by which the vaccines allegedly caused the GBS. The names of the petitioner's counsel and respondent's counsel are listed as Craig S.
Watson and Linda S. Renzi, respectively.
Theory of causation
Petitioner Rachal Lapairie alleged Guillain-Barré Syndrome (GBS) following receipt of an influenza and Tdap vaccine on October 8, 2013. Respondent denied causation. The parties reached a stipulation to resolve the case, and Special Master Laura D. Millman adopted the stipulation, awarding $195,000.00. The public decision does not detail the specific theory of causation, medical experts, or the mechanism of injury, stating only that the respondent denied causation. The award was a lump sum for all damages.
Source PDFs
USCOURTS-cofc-1_15-vv-01120